Dr Lipid

drlipid.bsky.social

06 November 2025 13:47

For those inquisitive about the next CETP inhibitor, obicetrapib, the following release from @NewAmsPharma will keep you up to date ir.newamsterdampharma.com/news-release... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social

Thanh Nha Thai, MD

thaithanhnha.bsky.social

07 May 2025 16:41

Our means for lowering LDL cholesterol keeps expanding. New RCT @nejm.org & @thelancet.bsky.social 1. Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. www.nejm.org/doi/full/10.... @eassociety.bsky.social @newamsterdampharma.bsky.social #CardioSky #EASCongress2025

Erin Michos, MD

erinmichos.bsky.social

31 March 2025 12:54

#ExpectMoreForLDL. Working together towards combating #ASCVD, the leading cause of morbidity & mortality. Exciting new options for LDL-C lowering. #ACC25 @newamsterdampharma.bsky.social

American College of Cardiology

accintouch.bsky.social

26 March 2025 12:55

Artie’s all packed—are you? 🎒 📱 #ACC25 App ✅ Pro Tip: Make sure to download the app & set ⏰ for your must-attend sessions! 💻 Laptop/Notebook ✅ 👟 Comfy Shoes ✅ 💙 ACC Blue for March 31 ✅ ⚡️ Excitement & Energy! ✅ 4️⃣ days to go! What's your must-have for ACC.25? 🤔 #CardioSky #MedSky

National Lipid Association

nationallipid.bsky.social

03 December 2024 20:23

Welcome to the National Lipid Association's official Bluesky page! Follow our other socials: @lipidjournal.bsky.social & @foundationofnla.bsky.social